Face Forward Aesthetics · Wexford, PA
Wegovy (semaglutide) and Zepbound (tirzepatide) are prescription medications that mimic gut hormones to regulate appetite and enhance glucose metabolism. They are self‐administered once weekly with a pen device and are titrated from a low dose to a target dose over several weeks. In clinical trials, adults taking Wegovy lost an average of 15 % of their body weight after 68 weeks, while those on the highest dose of Zepbound lost about 18 % after 72 weeks. Our providers support you every step, combining medication with nutrition and lifestyle coaching for sustainable results.
The injection itself takes seconds; appointments include coaching and monitoring
You’ll start with a low dose and increase gradually every four weeks until you reach the maintenance dose. Possible side effects include nausea, diarrhea or injection‐site reactions.
Once‐weekly injections; the program length varies based on your goals and medical guidance.
Average weight loss of 15-18% over 68-72 weeks when combined with diet and exercise.
Chelsea, DNP, FNP-C, has 6+ years of injecting experience, blending clinical expertise with artistry and strong patient connection. She loves midface filler and Dysport for natural, refreshed results. Her must-have is Plated Intense Serum.
View Profile
Victoria, DNP, FNP-BC, certified in aesthetics since 2023, is passionate about helping patients feel confident with subtle, natural results. She offers MOXI, RF microneedling, neurotoxins, and fillers. She loves Plated Skincare, especially the Exosome lineup.
View ProfileOur injectors have an artistic eye and use advanced techniques to deliver results that look full yet natural.
We use only FDA-approved products and prioritize cleanliness, safety, and your comfort at every visit.
Memberships help you save on treatments, and our referral program rewards you for sharing with friends.
8500 Brooktree Rd, Suite 120
Wexford, PA 15090
Learn more about Medical Weight Loss (Wegovy & Zepbound) at Face Forward Aesthetics
Prescription GLP‐1 agonist medications that help reduce appetite and support weight loss.
Via a once‐weekly subcutaneous injection using a pen device.
Clinical trials show average losses of 15% with Wegovy and 18% with Zepbound over roughly 68-72 weeks.
Possible side effects include nausea, diarrhea, constipation and injection‐site reactions; most improve over time.
Yes. Medication works best when combined with healthy eating and regular movement; we provide guidance.
Treatment length varies; many people stay on therapy until they reach their goal weight and develop sustainable habits.
They are FDA‐approved; your provider will evaluate your medical history and monitor you for any issues.
People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia Type 2 should avoid these drugs.
Schedule a consultation to discuss your goals and medical history; we’ll create a tailored weight‐loss plan.
Yes—weight loss and aesthetic treatments often complement each other; we’ll coordinate your plan for optimal results.
Book your consultation today and start your journey to a more confident you.